Abstract
This study provides a comprehensive analysis of available and emerging reproductive products and
technologies related to contraception and infertility treatments. The goal of this study is to
provide a comprehensive range of information from detailed product analyses through industry trends,
and to quantify and qualify the market for hormonal contraceptives, infertility pharmaceuticals, and
for assisted reproductive technologies.
The report forecasts the following markets through 2008: The world market oral contraceptives The
world market hormonal contraceptive devices The world market infertility pharmaceuticals, and The
U.S. market for assisted reproductive technologies (ART).
Not included are market forecasts for infertility diagnostics or surgical procedures to treat
fertility or over-the-counter contraceptives or diagnostics (such as spermicides, condoms, ovulation
or pregnancy testing kits). These markets are covered in other reports such as The U.S. Market for
Over-the-Counter Diagnostics and Over-the-Counter Womens Health
World market numbers include pharmaceuticals approved by the appropriate regulatory agency in the
U.S. and other countries, manufactured in the countries where the pharmaceuticals have been
approved, and shipped worldwide. World market numbers in this report do not include pharmaceuticals
manufactured in China or India by companies indigenous to those countries.
The information for this report was gathered using both primary and secondary research including
comprehensive research of secondary sources such as company literature, databases, investment
reports, and medical and business journals. Telephone interviews and email correspondence were the
primary method of gathering information. For the purpose of this study, Kalorama Information
interviewed key industry officials, consultants, healthcare providers, and government personnel.
These sources were the primary basis in gathering information specifically relating to revenue and
market share data presented in this report. Specific interviews with pharmaceutical company
representatives included marketing directors, division managers, and product representatives.